MEG3 and renal cell adenocarcinoma: In addition, MEG3 was identified as an inducer of RCC cell apoptosis by activating the mitochondrial pathway, as indicated by decreased Bcl-2 expression and elevated levels of cleaved caspase-9 and cytochrome c protein (107) (Figure 3).